Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing

INES LOHSE, DIANA J. AZZAM, HASSAN AL-ALI, CLAUDE-HENRY VOLMAR, SHAUN P. BROTHERS, TAN A. INCE and CLAES WAHLESTEDT
Anticancer Research August 2019, 39 (8) 4023-4030; DOI: https://doi.org/10.21873/anticanres.13558
INES LOHSE
1Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
2Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
3Molecular Therapeutics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIANA J. AZZAM
1Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
2Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
3Molecular Therapeutics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HASSAN AL-ALI
4Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
5Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
6Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
7Peggy and Harold Katz Drug Discovery Center, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAUDE-HENRY VOLMAR
1Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
2Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
3Molecular Therapeutics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHAUN P. BROTHERS
1Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
2Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
3Molecular Therapeutics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAN A. INCE
4Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
8Department of Pathology and Interdisciplinary Stem Cell Institute, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLAES WAHLESTEDT
1Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
2Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cwahlestedt@med.miami.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 39 no. 8 4023-4030
DOI 
https://doi.org/10.21873/anticanres.13558
PubMed 
31366484

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received May 1, 2019
  • Revision received May 28, 2019
  • Accepted June 6, 2019
  • Published online July 31, 2019.

Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. INES LOHSE1,2,3,*,
  2. DIANA J. AZZAM1,2,3,*,
  3. HASSAN AL-ALI4,5,6,7,
  4. CLAUDE-HENRY VOLMAR1,2,3,
  5. SHAUN P. BROTHERS1,2,3,
  6. TAN A. INCE4,8 and
  7. CLAES WAHLESTEDT1,2⇑
  1. 1Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  2. 2Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  3. 3Molecular Therapeutics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
  4. 4Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, U.S.A.
  5. 5Miami Project to Cure Paralysis, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  6. 6Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  7. 7Peggy and Harold Katz Drug Discovery Center, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  8. 8Department of Pathology and Interdisciplinary Stem Cell Institute, Miller School of Medicine, University of Miami, Miami, FL, U.S.A.
  1. Correspondence to: Claes Wahlestedt, Leonard M. Miller Professor, Director, Center for Therapeutic Innovation (CTI), Associate Dean for Therapeutic Innovation, Vice Chair for Research, Dept. Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Miami, FL 33136, U.S.A. Tel: +1 3052437694, e-mail: cwahlestedt{at}med.miami.edu
View Full Text

Cited By...

  • 7 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 39 (8)
Anticancer Research
Vol. 39, Issue 8
August 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing
INES LOHSE, DIANA J. AZZAM, HASSAN AL-ALI, CLAUDE-HENRY VOLMAR, SHAUN P. BROTHERS, TAN A. INCE, CLAES WAHLESTEDT
Anticancer Research Aug 2019, 39 (8) 4023-4030; DOI: 10.21873/anticanres.13558

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Ovarian Cancer Treatment Stratification Using Ex Vivo Drug Sensitivity Testing
INES LOHSE, DIANA J. AZZAM, HASSAN AL-ALI, CLAUDE-HENRY VOLMAR, SHAUN P. BROTHERS, TAN A. INCE, CLAES WAHLESTEDT
Anticancer Research Aug 2019, 39 (8) 4023-4030; DOI: 10.21873/anticanres.13558
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 5-Azacytidine (5-aza) Induces p53-associated Cell Death Through Inhibition of DNA Methyltransferase Activity in Hep3B and HT-29 Cells
  • Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma
  • Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway
Show more Experimental Studies

Similar Articles

Keywords

  • Ovarian cancer
  • ex vivo drug sensitivity screening
  • precision medicine
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire